⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL900364 | 0.74 | — | — | |
| SCHEMBL1396264 | 0.73 | — | — | |
| SCHEMBL22535876 | 0.73 | — | — | |
| SCHEMBL65965 | 0.71 | — | — | |
| SCHEMBL7080542 | 0.71 | — | — | |
| SCHEMBL28258959 | 0.71 | — | — | |
| SCHEMBL1023905 | 0.69 | THRB (0.30) | — | |
| SCHEMBL15518516 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL7524961 | 0.69 | — | — | |
| Butane SCHEMBL3693274 | 0.69 | TSHR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3813811-A2 | COMPOSITIONS AND METHODS FOR MEDIATING EPS | Research Institute at Nationwide Children's Hospital (US) | 2021-05-05 | — | — | EP | claimed |
| EP-1357881-A4 | INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION | QUARK PHARMACEUTICALS INC (US) | 2009-02-18 | — | — | EP | claimed |
| EP-1357881-A2 | INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION | Quark Biotech, Inc. (US) | 2003-11-05 | — | — | EP | claimed |
| US-20030203956-A1 | Method of using a cyclooxygenase-2 inhibitor and one or more ornithine decarboxylase inhibitors as a combination therapy in the treatment of neoplasia | PHARMACIA CORPORATION | 2003-10-30 | — | — | US | claimed |
| US-6482866-B1 | Viscoelastic surfactant fluids and related methods of use | SCHLUMBERGER TECHNOLOGY CORPORATION | 2002-11-19 | — | — | US | claimed |
| WO-2002058623-A2 | INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION | QUARK BIOTECH, INC. (US) | 2002-08-01 | — | — | WO | claimed |
| WO-2023249908-A1 | USE OF NON-TOXIC POLYAMINE ANALOGUES AND/OR INHIBITORS OF POLYAMINE BIOSYNTHESIS TO RE-BALANCE NATURAL POLYAMINE LEVELS IN SNYDER-ROBINSON SYNDROME AND RELATED DISORDERS | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-12-28 | — | — | WO | disclosed |
| EP-3813811-A2 | COMPOSITIONS AND METHODS FOR MEDIATING EPS | Research Institute at Nationwide Children's Hospital (US) | 2021-05-05 | — | — | EP | disclosed |
| WO-2017136533-A1 | METHODS FOR TREATING DIAGNOSING, AND MONITORING TREATMENT OF MUCOPOLYSACCHARIDOSES | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2017-08-10 | — | — | WO | disclosed |
| EP-2943189-A1 | METHODS AND COMP0STIONS FOR TREATMENT OF DEMYELINATING DISEASES | Pathologica LLC (US) | 2015-11-18 | — | — | EP | disclosed |
| EP-2846788-A1 | USE OF COMPOUNDS FOR THE TREATMENT OF PAIN | Akron Molecules AG (AT) | 2015-03-18 | — | — | EP | disclosed |
| WO-2014110154-A1 | METHODS AND COMP0STIONS FOR TREATMENT OF DEMYELINATING DISEASES | PATHOLOGICA LLC (US) | 2014-07-17 | — | — | WO | disclosed |
| EP-2665471-A2 | CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG | Pathologica, LLC. (US) | 2013-11-27 | — | — | EP | disclosed |
| EP-1141708-A1 | IDENTIFYING SMALL ORGANIC MOLECULE LIGANDS FOR BINDING | Sunesis Pharmaceuticals Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000046187-A2 | ANTIZYME MODULATORS AND THEIR USE | ORIDIGM CORPORATION (US) | 2000-08-10 | — | — | WO | disclosed |
| EP-1018876-A1 | USE OF HYDROXYLAMINE DERIVATIVES, AND METHOD AND PREPARATIONS FOR INCREASING THE TOLERANCE OF FIELD CROPS AGAINST WEATHER STRESSES | BIOREX KUTATO ES FEJLESZTÖ RT. (HU) | 2000-07-19 | — | — | EP | disclosed |
| WO-2000039585-A1 | IDENTIFYING SMALL ORGANIC MOLECULE LIGANDS FOR BINDING | SUNESIS PHARMACEUTICALS, INC. (US) | 2000-07-06 | — | — | WO | disclosed |
| WO-1998047362-A1 | USE OF HYDROXYLAMINE DERIVATIVES, AND METHOD AND PREPARATIONS FOR INCREASING THE TOLERANCE OF FIELD CROPS AGAINST WEATHER STRESSES | Biorex Kutató és Fejlesztó Rt. (HU) | 1998-10-29 | — | — | WO | disclosed |
| EP-0644873-A1 | ORNITHINE DECARBOXYLASE INHIBITING BRANCHED AMINOOXY AMINO ALKANE DERIVATIVES. | CIBA GEIGY AG (CH) | 1995-03-29 | — | — | EP | disclosed |
| WO-1994024094-A1 | ORNITHINE DECARBOXYLASE INHIBITING BRANCHED AMINOOXY AMINO ALKANE DERIVATIVES | CIBA-GEIGY AG (CH) | 1994-10-27 | — | — | WO | disclosed |